EUVIMEDEUVIMED entdecken
Crossref

Biomimetic Nanoarchitectonics with Chitosan Nanogels for Collaborative Induction of Ferroptosis and Anticancer Immunity for Cancer Therapy

Ning Yang, Xiuhua Pan, Xiawei Zhou, Zengyi Liu, Jie Yang, Jun Zhang, Zengguang Jia, Qi Shen iD

Advanced Healthcare Materials · 2024

DOI: 10.1002/adhm.202302752 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2024. Verfasst von Ning Yang und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Shanghai Jiao Tong University, 800 Dong Chuan Road, Shanghai, 200240, China. Hauptthemen laut MEDLINE: Chitosan, Ferroptosis, Neoplasms, Ferrous Compounds. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Nature Science Foundation of Chongqing.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immunogenic cell death (ICD) shows promising therapeutic potential for tumor regression. However, the low sensitivity and immunosuppressive state of current cell death manners seriously impede tumor immunogenicity. Ferroptosis characterized by excessive lipid peroxidation, has emerged as a potential strategy to induce ICD and activate antitumor immune responses. However, the effectiveness of ferroptosis is limited by antioxidant regulatory networks, including the glutathione peroxidase 4 (GPX4) and ferroptosis suppressor protein 1 (FSP1) pathways, presenting challenges for its induction. Herein, they propose a novel approach that involves utilizing functionalized chitosan‐ferrocene‐sodium alginate (CFA) crosslinked nanogels, which are modified to pravastatin (PRV) and M1 macrophage membrane (MM) (designing as CFA/PRV@MM). Specifically, ferrocene boots intracellular reactive oxygen species levels for efficient glutathione (GSH) depletion through Fenton reaction, thus disrupting the GPX4/GSH axis, while PRV intervenes in the mevalonate pathway to inhibit the FSP1/CoQ10 antioxidant axis, thereby synergistically causing pronounced ferroptotic damage and promoting ICD. The CFA/PRV@MM nanogels demonstrate superior therapeutic efficacy in a mouse breast model, resulting in effective tumor ablation and immune response with minimal side effects. RNA transcription analysis reveals that nanogels can significantly affect metabolic progress, as well as immune activation. This research provides valuable insights into the design of ferroptosis induction for cancer immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ChitosanFerroptosisNeoplasmsFerrous CompoundsAnimalsMiceMetallocenesNanogelsAntioxidantsBiomimeticsAlginatesDisease Models, AnimalGlutathione

Stichwörter der Autor:innen

antitumor therapyferroptosisferroptosis suppressor protein 1/coenzyme Q10glutathione peroxides 4/glutathioneimmunogenic cell death

Substanzen

ChitosanferroceneMetallocenesNanogelsAntioxidantsAlginatesGlutathioneFerrous Compounds

Autor:innen und Institutionen

  • School of Pharmacy, Shanghai Jiao Tong University, 800 Dong Chuan Road, Shanghai, 200240, China.

ORCID-Profile: Qi Shen

Förderung

  • National Natural Science Foundation of China
  • Nature Science Foundation of Chongqing

Zitieren

APA

Yang, N., Pan, X., Zhou, X., Liu, Z., Yang, J., Zhang, J., Jia, Z., & Shen, Q. (2024). Biomimetic Nanoarchitectonics with Chitosan Nanogels for Collaborative Induction of Ferroptosis and Anticancer Immunity for Cancer Therapy. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202302752

Vancouver

Yang N, Pan X, Zhou X, Liu Z, Yang J, Zhang J, et al. Biomimetic Nanoarchitectonics with Chitosan Nanogels for Collaborative Induction of Ferroptosis and Anticancer Immunity for Cancer Therapy. Advanced Healthcare Materials. 2024. doi:10.1002/adhm.202302752

BibTeX
@article{Yang2024,
  author = {Yang, Ning and Pan, Xiuhua and Zhou, Xiawei and Liu, Zengyi and Yang, Jie and Zhang, Jun and Jia, Zengguang and Shen, Qi},
  title = {Biomimetic Nanoarchitectonics with Chitosan Nanogels for Collaborative Induction of Ferroptosis and Anticancer Immunity for Cancer Therapy},
  journal = {Advanced Healthcare Materials},
  year = {2024},
  doi = {10.1002/adhm.202302752}
}
Kostenlos starten →